SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-005696
Filing Date
2019-06-14
Accepted
2019-06-14 08:05:32
Documents
3
Period of Report
2019-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 nviv-20190611x8k.htm 8-K 42192
2 nviv-20190611ex991d421b7.htm EX-99.1 22333
3 nviv20190611ex991d421b7001.jpg GRAPHIC 5107
  Complete submission text file 0001558370-19-005696.txt   73044
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 19897605
SIC: 3841 Surgical & Medical Instruments & Apparatus